ARCT
Price
$12.52
Change
-$0.38 (-2.95%)
Updated
Jun 11, 04:07 PM (EDT)
Capitalization
349.86M
61 days until earnings call
TRDA
Price
$8.21
Change
-$0.05 (-0.61%)
Updated
Jun 11, 02:58 PM (EDT)
Capitalization
313.5M
56 days until earnings call
Interact to see
Advertisement

ARCT vs TRDA

Header iconARCT vs TRDA Comparison
Open Charts ARCT vs TRDABanner chart's image
Arcturus Therapeutics Holdings
Price$12.52
Change-$0.38 (-2.95%)
Volume$100
Capitalization349.86M
Entrada Therapeutics
Price$8.21
Change-$0.05 (-0.61%)
Volume$340
Capitalization313.5M
ARCT vs TRDA Comparison Chart
Loading...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARCT vs. TRDA commentary
Jun 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCT is a Hold and TRDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 11, 2025
Stock price -- (ARCT: $12.90 vs. TRDA: $8.26)
Brand notoriety: ARCT and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARCT: 150% vs. TRDA: 84%
Market capitalization -- ARCT: $349.86M vs. TRDA: $313.5M
ARCT [@Biotechnology] is valued at $349.86M. TRDA’s [@Biotechnology] market capitalization is $313.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $333.72B to $0. The average market capitalization across the [@Biotechnology] industry is $2.4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARCT’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • ARCT’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than ARCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARCT’s TA Score shows that 6 TA indicator(s) are bullish while TRDA’s TA Score has 5 bullish TA indicator(s).

  • ARCT’s TA Score: 6 bullish, 2 bearish.
  • TRDA’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, ARCT is a better buy in the short-term than TRDA.

Price Growth

ARCT (@Biotechnology) experienced а -0.77% price change this week, while TRDA (@Biotechnology) price change was +0.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.20%. For the same industry, the average monthly price growth was +14.37%, and the average quarterly price growth was +6.48%.

Reported Earning Dates

ARCT is expected to report earnings on Aug 11, 2025.

TRDA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+5.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARCT($350M) has a higher market cap than TRDA($313M). ARCT YTD gains are higher at: -23.983 vs. TRDA (-52.227). TRDA has higher annual earnings (EBITDA): 7.89M vs. ARCT (-77.4M). TRDA has more cash in the bank: 383M vs. ARCT (237M). ARCT has less debt than TRDA: ARCT (28.6M) vs TRDA (57M). TRDA has higher revenues than ARCT: TRDA (172M) vs ARCT (138M).
ARCTTRDAARCT / TRDA
Capitalization350M313M112%
EBITDA-77.4M7.89M-981%
Gain YTD-23.983-52.22746%
P/E RatioN/A14.24-
Revenue138M172M80%
Total Cash237M383M62%
Total Debt28.6M57M50%
FUNDAMENTALS RATINGS
ARCT: Fundamental Ratings
ARCT
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARCTTRDA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 20 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
64%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SVIIX9.70N/A
N/A
Virtus Ceredex Large-Cap Value Equity A
IBNAX24.20N/A
N/A
Macquarie Balanced Fund Class A
BIGTX14.75N/A
N/A
The Texas I
ATHGX29.16N/A
N/A
American Century Heritage R5
MASOX9.86N/A
N/A
MoA Small Cap Equity Index Fund